Wednesday, 25 September 2019

Paternal genomic imprinting on embryo


What is Genomic imprinting ??  A paternal contribution to embryogenesis
It is evident through a number of studies about the paternal contribution to embryogenesis. Genomic imprinting could be one of the paternal factors involved in embryogenesis, because most of the genes involved in embryo growth and development are imprinted, i.e. they are expressed from one specific
parental allele. Our earlier studies on the effect of tamoxifen, a selective estrogen receptor modulator, on fertility of adult male rats have shown an increase in early post-implantation embryo loss in females mated with the tamoxifen treated males. The sperm fertilizing ability was not affected. These studies suggested that paternal tamoxifen treatment affected embryogenesis. Further studies were done to understand the mechanism of increased embryo loss. The effect on the
expression of Igf2, a major growth–promoting factor in the early embryo was studied in the normal and resorbed embryos (post-implantation loss). It was observed that resorbed embryos showed significant reduction in Igf2 transcript.
Igf2 is an imprinted gene expressed in the early embryo from the paternal allele.
The paternal specific expression of Igf2 is due to the differential DNA methylation of an imprinting control region (ICR) located downstream of Igf2 gene on the two parental allele during gametogenesis. The ICR also controls the expression of a reciprocally imprinted gene, H19. On the paternal allele the ICR
is methylated and so Igf2 is expressed whereas on


No comments:

Post a Comment